CN Patent

CN1195550C — 外用剂

Assigned to Taisho Pharmaceutical Co Ltd · Expires 2005-04-06 · 21y expired

What this patent protects

本发明是一种配合有碱性药物、聚乙烯吡咯烷酮以及羧乙烯聚合物、且pH为4～9的范围的外用剂。通过本发明，有可能提供一种即使在皮肤的损伤部位也能够达到药物的长效化的新型的外用剂。

USPTO Abstract

本发明是一种配合有碱性药物、聚乙烯吡咯烷酮以及羧乙烯聚合物、且pH为4～9的范围的外用剂。通过本发明，有可能提供一种即使在皮肤的损伤部位也能够达到药物的长效化的新型的外用剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1195550C
Jurisdiction
CN
Classification
—
Expires
2005-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Taisho Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.